Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.83)
# 3,130
Out of 4,884 analysts
170
Total ratings
43.66%
Success rate
-1.93%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRTC iRhythm Technologies | Maintains: Overweight | $130 → $160 | $142.47 | +12.30% | 16 | Jun 11, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $115 → $95 | $93.67 | +1.42% | 12 | May 6, 2025 | |
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $544.47 | +19.38% | 13 | Dec 2, 2024 | |
| SGHT Sight Sciences | Maintains: Equal-Weight | $7 → $5 | $4.21 | +18.76% | 15 | Nov 11, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $10.32 | +16.28% | 12 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $129.19 | -26.46% | 12 | Feb 28, 2024 | |
| MDT Medtronic | Maintains: Overweight | $104 → $98 | $88.39 | +10.87% | 9 | Nov 22, 2023 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $87.78 | -3.17% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $30.72 | -51.17% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $301.05 | +13.93% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $2.78 | +403.60% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $31.01 | +54.79% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $76.79 | +32.83% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $104.32 | -44.40% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $13.88 | +44.09% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $82.93 | +57.96% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $134.44 | -1.07% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $395.28 | -44.34% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $119.90 | +215.26% | 2 | Feb 25, 2022 |
iRhythm Technologies
Jun 11, 2025
Maintains: Overweight
Price Target: $130 → $160
Current: $142.47
Upside: +12.30%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Equal-Weight
Price Target: $115 → $95
Current: $93.67
Upside: +1.42%
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $544.47
Upside: +19.38%
Sight Sciences
Nov 11, 2024
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $4.21
Upside: +18.76%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $10.32
Upside: +16.28%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $129.19
Upside: -26.46%
Medtronic
Nov 22, 2023
Maintains: Overweight
Price Target: $104 → $98
Current: $88.39
Upside: +10.87%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $87.78
Upside: -3.17%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $30.72
Upside: -51.17%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $301.05
Upside: +13.93%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $2.78
Upside: +403.60%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $31.01
Upside: +54.79%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $76.79
Upside: +32.83%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $104.32
Upside: -44.40%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $13.88
Upside: +44.09%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $82.93
Upside: +57.96%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $134.44
Upside: -1.07%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $395.28
Upside: -44.34%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $119.90
Upside: +215.26%